GPT and diabetes mellitus: In the current study, morin treatment slightly, but not significantly, corrected the alter levels of liver and kidney function biomarkers including ALT, AST, ALP, BUN and Cr, which might suggest the protective role of morin against the metabolic changes associated with diabetes.